Latigo Biotherapeutics Funding: $135M Raised, Series A
Latigo Biotherapeutics is a Biotech company based in Thousand Oaks, California. It has raised $135M in total funding. Latest round: Series A.
Latigo Biotherapeutics funding overview
Latigo Biotherapeutics is a Biotech company based in Thousand Oaks, California. Latigo Biotherapeutics has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2024. The round record for Latigo Biotherapeutics runs through 2024; nothing later has been disclosed. Investors on record include Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures. 4 distinct backers are named across the disclosed rounds.
Latigo Biotherapeutics at a glance
Total raised
$135M
Latest round
Series A
Latest round date
February 2024
Industry
Biotech
Headquarters
Thousand Oaks, California
Notable investors
Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures
Frequently asked about Latigo Biotherapeutics funding
How much has Latigo Biotherapeutics raised?
Latigo Biotherapeutics has raised $135M in total disclosed funding across the rounds on record.
Who has invested in Latigo Biotherapeutics?
Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures are named among the investors backing Latigo Biotherapeutics.
What was the latest Latigo Biotherapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2024.
Where is Latigo Biotherapeutics based?
Latigo Biotherapeutics is based in Thousand Oaks, California.
What sector does Latigo Biotherapeutics operate in?
Latigo Biotherapeutics is tracked under Biotech from Thousand Oaks, California, with $135M in disclosed funding.
When did Latigo Biotherapeutics last raise?
The last disclosed Latigo Biotherapeutics round closed in February 2024 at Series A.
Latigo Biotherapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Thousand Oaks below to benchmark round size and investor mix.
